Covidien International Finance S.A., established in Luxembourg, serves as a finance subsidiary within the global healthcare sector, primarily focusing on funding initiatives for its parent company, Medtronic. The firm plays a crucial role in the financial architecture of Medtronic by offering various financial instruments, including debt securities tailored to meet funding needs and optimize capital structure.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| MDT 6.55% 2037-10-15 USDCovidien International Finance S.A. | Luxembourg | 2037-10-15 | 6.550 | 4.89 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, Covidien International Finance S.A. has actively engaged in bond issuances, with a notable inaugural bond series launched in 2004 to support corporate growth initiatives. Significant issuances include a $1 billion offering in 2016 that financed Medtronic's acquisition of Covidien Plc, reflecting the company’s strategic expansion efforts. Currently, the yield on its bonds is competitive within the healthcare sector, attracting interest from retail investors, while select bonds feature flexible redemption options that enhance their appeal.